Diabetic Complications Cardiovascular: Clinical Trials

1 not yet recruiting. 1 Phase 2.

By phase and status

Phase	Trials	Status
Phase 2	1	Not yet recruiting 1

Follow Diabetic Complications Cardiovascular: new trials by email Literature Review of Diabetic Complications Cardiovascular trials Research Report on Diabetic Complications Cardiovascular

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

Trial	Phase	Status	Sponsor	Enrollment	Start	Updated
Prevention of Chronic Kidney Disease(CDK) Progression in Type 1 Diabetes With Long Term Use of Sodium-Glucose-coTransporter Inhibitors Avoiding Kidney hypOxia Sotagliflozin, Placebo - Nephropathy, Diabetic Nephropathies	Phase 2	Not yet recruiting	Steno Diabetes Center Copenhagen	69	2025-02-01	2025-01-27

Narrower conditions

Albuminuria (1)  ·  Diabetes Mellitus, Type 1 (1)  ·  Diabetic Nephropathies (1)  ·  Hypoxia (1)  ·  Kidney Diseases (1)

Broader conditions

Autoimmune Diseases (1)  ·  Diabetes Complications (1)  ·  Diabetes Mellitus (1)  ·  Endocrine System Diseases (1)  ·  Female Urogenital Diseases (1)  ·  Female Urogenital Diseases and Pregnancy Complications (1)  ·  Glucose Metabolism Disorders (1)  ·  Immune System Diseases (1)  ·  Male Urogenital Diseases (1)  ·  Metabolic Diseases (1)  ·  Nutritional and Metabolic Diseases (1)  ·  Pathological Conditions, Signs and Symptoms (1)  ·  Proteinuria (1)  ·  Signs and Symptoms (1)  ·  Signs and Symptoms, Respiratory (1)

Interventions

(2S,3R,4R,5S,6R)-2-(4-chloro-3-(4-ethoxybenzyl)phenyl)-6-(methylthio)tetrahydro-2H-pyran-3,4,5-triol (1)

Sponsors

Steno Diabetes Center Copenhagen (1)

Countries

Denmark (1)  ·  United Kingdom (1)